Is Low Libido Normal in Endometriosis?

Is Low Libido Normal in Endometriosis?

Yes, low libido is extremely common in endometriosis — but it is not something you simply have to accept. Studies estimate that 66–70% of people with endometriosis report significantly reduced sexual desire, driven by overlapping mechanisms: chronic pain, estrogen dominance, inflammation, and nutrient deficiencies that blunt hormonal signaling. The key caveat is that each driver requires a different intervention, so a blanket "try this supplement" approach rarely works without first identifying which mechanisms are active in your body.

---

Why Endometriosis Specifically Suppresses Sexual Desire

Endometriosis is an inflammatory, hormone-dependent condition in which endometrial-like tissue grows outside the uterus. That description, while clinical, understates how profoundly it disrupts the biological machinery behind libido.

Three mechanisms stand out in the literature:

1. Chronic inflammatory load. Endometriotic lesions produce excess prostaglandins and pro-inflammatory cytokines — particularly IL-6 and TNF-α. Elevated systemic inflammation suppresses hypothalamic-pituitary-ovarian (HPO) axis signaling, reducing the pulsatile release of LH that drives testosterone production (Augoulea et al., Gynecological Endocrinology 2012; PMID: 22468712). Testosterone in people with ovaries is the primary hormonal driver of sexual desire, so even mild suppression matters.

2. Estrogen dominance and progesterone deficiency. Endometriosis is an estrogen-dependent disease. The relative excess of estrogen to progesterone dysregulates androgen receptor sensitivity, meaning that even when testosterone is technically within range, it may not transduce a normal desire signal (Bulun et al., Endocrine Reviews 2019; PMID: 30994890).

3. Dyspareunia feedback loop. Deep infiltrating endometriosis causes pain during or after intercourse in up to 50% of patients (Ferrero et al., Human Reproduction 2005; PMID: 15760959). The nervous system learns to associate sexual arousal with anticipated pain, creating a conditioned suppression of desire that persists even when the pain is managed pharmacologically. This is a neurological process, not a psychological weakness.

For a broader look at how endometriosis disrupts mood and motivation — both of which feed into libido — see our article on what causes low mood in endometriosis.

---

Lab Tests for Low Libido: What to Measure First

Before reaching for any supplement, testing your actual biochemistry is essential. Many of the contributing factors are invisible without bloodwork. Below are the markers most relevant to libido in the context of endometriosis.

If you have not had comprehensive bloodwork done, asking your provider for a panel that includes free testosterone, SHBG, hs-CRP, 25-OH Vitamin D, ferritin, zinc, and an Omega-3 Index is a reasonable starting point. Platforms like Function Health have made comprehensive lab panels more accessible without requiring a specialist referral.

---

Low Libido and Nutrient Deficiencies: The Hidden Drivers

Nutrient gaps are rarely discussed in the context of endometriosis-related low libido, yet several deficiencies directly impair the hormonal and neurological pathways that generate desire.

Vitamin D

Vitamin D functions as a steroid hormone precursor, with receptors on ovarian cells and in the brain regions governing sexual motivation. A 2015 systematic review found that women with endometriosis had significantly lower 25-OH Vitamin D levels than controls, and that low D correlated with greater pain and inflammatory cytokine burden (Harris et al., BJOG 2018; PMID: 29265728). Supplementation to achieve serum levels above 40 ng/mL has been associated with meaningful reductions in pelvic pain scores in randomized trials. For a detailed breakdown of how deficiency presents and how to correct it, see our guide on low vitamin D symptoms, causes, and lab markers.

Omega-3 Fatty Acids

Omega-3s — specifically EPA and DHA — inhibit the cyclooxygenase enzymes that produce pro-inflammatory prostaglandins (PGE2) implicated in endometriosis pain (Missmer et al., Human Reproduction 2010; PMID: 20570972). Lower prostaglandin-driven pain directly reduces the dyspareunia feedback loop described above. Separately, DHA is a structural component of neuronal membranes in regions governing sexual arousal. A low Omega-3 Index (below 4%) is associated with blunted reward signaling. Curious whether Omega-3 has a more direct role? See does Omega-3 help with low libido for the full evidence review.

Zinc

Zinc is a cofactor in the enzymatic pathway that converts cholesterol to testosterone. Serum zinc below 70 mcg/dL is associated with a statistically significant reduction in free testosterone in multiple cohorts. In endometriosis specifically, elevated prostaglandins increase zinc excretion, making deficiency more likely even with adequate dietary intake.

Magnesium

Magnesium modulates the hypothalamic-pituitary axis and is required for progesterone synthesis. It also plays a direct role in smooth muscle relaxation — relevant for reducing pelvic tension and dyspareunia. Many people with endometriosis are functionally magnesium-deficient even with normal serum levels, because serum magnesium is a poor proxy for intracellular stores. RBC magnesium is a more reliable marker.

---

Vitamins for Low Libido: What the Evidence Actually Supports

The supplement market is noisy. Here is what has meaningful evidence specifically in the context of inflammatory, hormone-driven low libido:

Vitamin D3 + K2 (MK-7): D3 at doses sufficient to bring serum 25-OH D above 40 ng/mL has demonstrated reductions in endometriosis-associated pain in randomized controlled trials. K2 in the MK-7 form improves D3's utilization and reduces the risk of soft-tissue calcium deposition at higher D3 doses.

Omega-3 (EPA/DHA at ≥ 2g/day): Anti-inflammatory at the prostaglandin level; addresses the pain-desire feedback loop directly. The clinical threshold for measurable anti-inflammatory effect is typically 2–3g EPA+DHA combined daily.

Magnesium Glycinate: Superior bioavailability compared to magnesium oxide; supports progesterone synthesis and reduces pelvic muscle tension. Clinical trials use doses of 300–400mg elemental magnesium daily.

Zinc (as bisglycinate or picolinate): 25–40mg daily in trials showing testosterone-supporting effects. Important: excess zinc depletes copper, so a 10:1 zinc-to-copper ratio is recommended for extended supplementation.

Ashwagandha (KSM-66): A 2015 double-blind RCT in women found that KSM-66 at 300mg twice daily significantly improved scores on the Female Sexual Function Index (FSFI) compared to placebo (Dongre et al., BioMed Research International 2015; PMID: 26609282). The mechanism appears to be cortisol reduction — chronic stress suppresses HPO axis signaling, and ashwagandha interrupts this at the level of the adrenal response. For more on ashwagandha's specific role in libido, see does ashwagandha help with low libido.

---

Low Oxytocin Symptoms: The Overlooked Hormone

Oxytocin is rarely included in standard endometriosis discussions, yet its role in sexual desire and pair bonding is well-established. Low oxytocin symptoms include reduced motivation for intimacy, emotional blunting, difficulty with arousal even when pain is absent, and a generalized sense of disconnection from one's body.

Chronic pain states — including endometriosis — are associated with downregulation of oxytocin receptor density in the hypothalamus (Jurek & Neumann, Physiological Reviews 2018; PMID: 29897293). This is a neuroadaptive response to sustained pain signaling: the brain dampens its own reward-anticipation circuitry to protect against repeated disappointment.

Oxytocin is not directly supplementable in oral form (it degrades in the gut), but its release is facilitated by:

• Physical touch and non-sexual intimacy (demonstrated to raise plasma oxytocin by 20–30% in trials)
• Magnesium adequacy (magnesium gates NMDA receptors involved in oxytocin secretion)
• Reduced cortisol load (elevated cortisol competes with oxytocin at receptor sites)
• Regular low-intensity aerobic exercise (shown to elevate oxytocin mRNA expression in rat hypothalami, with analogous mechanisms proposed in humans)

Addressing magnesium status and cortisol dysregulation through adaptogens like ashwagandha may therefore partially restore oxytocin signaling — indirectly, but meaningfully.

---

What This Means for Your Formula

Because the drivers of low libido in endometriosis are multi-system — inflammatory, hormonal, neurological, and nutritional — a one-size supplement stack is unlikely to be adequate. What actually matters is calibrating to your specific bloodwork.

Ones analyzes your lab results, wearable data, and health history to build a personalized capsule formula. For someone with endometriosis-related low libido, a Ones formula might include:

• Omega-3 (EPA/DHA) dosed at a clinically effective level based on your actual Omega-3 Index, targeting the prostaglandin and neuroinflammatory pathways that suppress desire
• Vitamin D3 + K2 (MK-7) titrated to achieve a serum 25-OH D above 40 ng/mL — not the generic 1,000 IU that leaves most people short
• Ashwagandha KSM-66 at 600mg — the dose used in published female sexual function trials — included if cortisol dysregulation or adrenal stress is identified in your data
• Magnesium Glycinate at 300–400mg elemental, if RBC magnesium indicates intracellular depletion

The formula is assembled as a 6 or 9-capsule daily plan, determined by the AI based on your findings — not a plan you pick off a menu.

---

Key Takeaways

• Low libido affects an estimated 66–70% of people with endometriosis and is driven by at least three distinct biological mechanisms: inflammation, estrogen dominance, and the pain-desire feedback loop.
• Lab testing — including free testosterone, SHBG, hs-CRP, 25-OH Vitamin D, Omega-3 Index, zinc, and RBC magnesium — is the essential first step before choosing any supplement protocol.
• Nutrient deficiencies in vitamin D, omega-3, zinc, and magnesium each impair the specific hormonal and enzymatic pathways that generate sexual desire.
• Ashwagandha KSM-66 at 600mg daily has RCT-level evidence for improving female sexual function scores, likely through cortisol reduction and HPO axis normalization.
• Low oxytocin symptoms — emotional blunting, reduced motivation for intimacy — are a real and measurable consequence of chronic pain states, addressable in part through magnesium repletion and cortisol management.
• Blanket supplement stacks are rarely effective; personalization to your actual biomarkers is the most reliable path to meaningful improvement.

---

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before beginning any supplement regimen, particularly if you have a diagnosed condition such as endometriosis.